Is Weed Legal in Zimbabwe? Understanding Zimbabwe Cannabis and Marijuana Laws (2026)

Weed is partly legal in Zimbabwe. The country legalised the cultivation and processing of cannabis for medicinal and scientific use in 2018, and it has since built a separate licensing system for industrial hemp. What remains firmly illegal is recreational cannabis: growing, possessing, or selling it for personal use is still a criminal offence. Zimbabwe’s reform is part of a wider shift across Africa, where governments have turned to cannabis as an export crop while keeping personal use prohibited.

Is Weed Legal in Zimbabwe?

Cannabis is legal in Zimbabwe only for licensed medicinal, scientific, and industrial purposes — not for recreational use. The legal foundation is Statutory Instrument 62 of 2018, the Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) Regulations, which the Minister of Health and Child Care issued under the Dangerous Drugs Act. There is no “Medicinal Cannabis Industry Act”; the framework is a set of regulations administered by the health ministry through the Medicines Control Authority of Zimbabwe (MCAZ).

The scope is narrow. Cannabis grown under a Zimbabwean medical licence is currently for export only, and any local use is restricted to research and development. Possession, cultivation, and use of cannabis outside the licensed medical and hemp systems remain criminal offences that can carry lengthy prison terms. Cannabis has been outlawed in Zimbabwe since the colonial-era Dangerous Drugs Act of 1955, and the 2018 regulations carved out a licensed exception rather than decriminalising the plant.

How Did Zimbabwe Legalise Medical Cannabis?

Zimbabwe legalised medical cannabis in 2018, becoming the second African country to do so after Lesotho, which issued its first cultivation licences in 2017. The change came through Statutory Instrument 62 of 2018, which allowed individuals and companies to apply for licences to cultivate and process cannabis for medicinal and scientific use.

The driving motive was economic. Zimbabwe is Africa’s largest tobacco producer, and tobacco still accounts for roughly a fifth of the country’s export earnings. With anti-smoking campaigns shrinking global tobacco demand, officials framed cannabis as a high-value cash crop that could diversify agriculture and bring in foreign currency. Government figures floated the idea of a billion-dollar industry built mainly on exports — an ambitious projection that the sector has yet to come close to meeting.

Who Regulates Cannabis and Hemp in Zimbabwe?

Three agencies share oversight, depending on the product. The Medicines Control Authority of Zimbabwe regulates medicinal cannabis on behalf of the Ministry of Health and Child Care, handling licensing, testing, and compliance. Industrial hemp falls to the Agricultural Marketing Authority (AMA), which issues hemp permits under the Ministry of Lands and Agriculture. The Zimbabwe Investment and Development Agency (ZIDA) runs the investment side, processing medicinal-cannabis applications through its One-Stop Investment Services Centre before passing them to the health regulator.

Splitting medicinal cannabis from industrial hemp between two regulators is the defining feature of Zimbabwe’s system. The dividing line is potency: medicinal cannabis contains more than 1% THC and is controlled by the MCAZ, while hemp sits below that threshold and is overseen by the AMA.

Can You Grow Weed at Home in Zimbabwe?

No. Home growing for personal or recreational use is illegal, and there is no personal-cultivation allowance of the kind neighbouring South Africa introduced through its courts. The only legal route to growing cannabis is a commercial licence, and the rules are demanding.

Statutory Instrument 62 of 2018 provides for two licence categories: a cultivation-and-research licence for research and development, and a cultivation-and-production licence that also permits production for export. Both run for five years from the date of issue. Producers must grow in greenhouses to meet “organically grown” standards, and licensed sites have to be secured with perimeter fencing, CCTV, access control, and air-filtration systems to contain odour and pollen. Cultivation cannot begin until the MCAZ inspects the site and the Secretary for Health issues written authorisation.

How Much Does a Cannabis Licence Cost in Zimbabwe?

A medicinal cannabis production licence is expensive: a five-year licence costs US$50,000, on top of substantial annual inspection and renewal fees. According to a peer-reviewed study of Zimbabwe’s cannabis sector published in The Journal of Peasant Studies, the fee schedule under the 2018 regulations runs from roughly US$5,000 for a research licence to US$50,000 for a production licence, with an inspection fee of US$2,500, a ZIDA application fee of around US$11,250, an annual return fee near US$15,000, and renewal costs of about US$20,000.

The capital costs dwarf the licence fees. Researchers from Cardiff University and the University of Cape Town, writing in The Conversation, found that even a cheaper greenhouse can cost about US$220,000 for a five-hectare plot. The result is a sector dominated by well-capitalised local businesses and foreign investors, often through joint ventures, while the small-scale farmers who grew cannabis for generations are largely shut out.

Is CBD Legal in Zimbabwe?

CBD is legal in Zimbabwe when it is sold as a registered complementary medicine. The MCAZ recognises cannabidiol as a complementary medicine under the country’s Complementary Medicines Regulations, and in 2022 it opened the domestic market by inviting licensed producers, manufacturers, importers, exporters, and pharmacists to apply to register and sell hemp-based CBD products — the first time cannabis products could be sold to the public in Zimbabwe.

The approval is conditional. Only registered, pharmaceutical-form CBD products are permitted, and the regulator has warned that unapproved products may be confiscated and their sellers prosecuted. For consumers, that means legitimate CBD on a Zimbabwean shelf should be a registered complementary medicine rather than an unregulated import.

Industrial Hemp in Zimbabwe

Industrial hemp has its own, more accessible framework. Zimbabwe legalised hemp production and marketing through Statutory Instrument 218 of 2020, the Agricultural Marketing Authority (Industrial Hemp) Regulations, gazetted in September 2020. The AMA issues three permit types — cultivator, merchant, and research-and-breeding — with cultivator and merchant permits valid for one year and research-and-breeding permits for three years.

Zimbabwe also draws the hemp line differently from most of the world. The Criminal Law (Codification and Reform) Amendment Act of 2023 removed industrial hemp from the list of dangerous drugs and defined it as Cannabis sativa containing no more than 1% delta-9-THC on a dry-weight basis — well above the 0.3% threshold used in the United States and Europe, and matching the 1% limit also used in Malawi. Understanding that potency cut-off matters, because it is the legal boundary between a regulated agricultural crop and a controlled drug — the same hemp-versus-marijuana distinction that shapes cannabis law worldwide.

Hemp permits are far cheaper than medical licences — cultivator and research permits cost US$200 and merchant permits US$500, after the government cut hemp fees at the end of 2020 to attract growers. So far the early hemp sector has been dominated by CBD flower grown for export, with shipments reported to Switzerland, Poland, and Germany. Local seed access, financing, and value-addition remain persistent bottlenecks, themes echoed at industry events such as a recent Zimbabwe hemp seminar.

Cannabis and Zimbabwe’s Economy

Cannabis is being positioned as part of Zimbabwe’s answer to a fragile economy and a declining tobacco market, but the payoff so far has been modest. The global legal cannabis market is worth roughly US$70 billion and is forecast to grow several times over within the next decade, and Zimbabwe’s subtropical climate and low labour costs make it a credible production base. The government has courted investors with projects such as a planned agro-industrial park near Goromonzi built around cannabis and hemp.

The reality on the ground has lagged the rhetoric. High licence fees, costly greenhouse requirements, currency instability, and the friction of exporting a product still restricted under international drug-control treaties have all slowed the build-out. Many licence holders have spent years constructing sites rather than harvesting, and some early investors have scaled back. The benefits have concentrated among a small group of well-funded operators rather than the broad rural base the reforms were meant to lift — a pattern documented across Africa’s emerging cannabis markets.

Why the Illicit Market Persists

An illegal cannabis market continues to thrive alongside the legal one, largely because the legal system was not built for the people who already grow the plant. Cannabis — known locally as mbanje — has long been cultivated and traded informally for traditional, medicinal, and recreational use. The 2018 reforms criminalised that activity while reserving the legal market for those who can afford the licences, greenhouses, and compliance costs.

Because recreational use remains prohibited and the formal sector is geared toward export rather than domestic supply, ordinary cultivators see little incentive to move into the legal system. Analysts who study Zimbabwe’s reform argue that excluding legacy growers undermines the policy’s own goals, since the illicit trade simply continues to meet local demand.

What’s Next for Cannabis in Zimbabwe?

The near-term outlook is incremental rather than transformative. Medicinal cannabis grown in Zimbabwe is still export-only, the domestic medical market runs largely through registered CBD complementary medicines, and there is no sign that the government intends to legalise recreational use. The active debates are about execution: lowering barriers for small farmers, adding value beyond raw CBD flower, securing reliable seed and financing, and building export channels that satisfy both regulators and international buyers.

For anyone weighing the opportunity, the practical takeaway is unchanged. Medicinal cannabis and industrial hemp are open to licensed operators under tightly defined rules, CBD is available as a regulated complementary medicine, and recreational cannabis remains illegal. Zimbabwe’s experience also offers a wider lesson for the continent, captured in our look at what to weigh as Africa warms up to cannabis legalisation: writing reform into law is the easy part, and building an inclusive industry around it is the real test.